Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-54.77	10.66	23.57
Graham Fair Price	41.42	2.27	1.61
PEG	-89.31	0.07	-0.68
Price/Book	-10.88	0.96	1.08
Price/Cash Flow	-70.64	-38.72	131.90
Prices/Earnings	-55.44	7.28	16.33
Price/Sales	-55.44	0.88	1.97
Price/FCF	-70.64	-38.72	131.90
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-6.62	0.22	0.24
Operating Margin	-0.86	0.11	0.11
ROA	100.00	0.01	< 0.005
ROE	0.02	0.03	100.00
ROIC	0.02	0.04	96.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.01	< 0.005	149.96
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.22	0.98	339.31
EPS QOQ	-0.24	1.00	316.90
FCF QOQ	-0.88	-4.04	-360.47
Revenue QOQ	-0.46	1.00	118.67
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	83.54	40.92	-51.01
Days Sales Outstanding (DSO)	54.79	27.47	-49.87
Inventory Turnover	1.08	2.20	104.13
Debt/Capitalization	0.56	0.57	0.56
Quick Ratio	1.20	1.20	0.17
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	2.63	2.63	< 0.005
Cash	0.47	0.47	< 0.005
Capex	-0.09	-0.18	-103.44
Free Cash Flow	0.02	-0.07	203.59
Revenue	1.45	2.90	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.11	2.11	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.10	5.82	-51.92
Naive Interpretation	Member

06 - Financial Health · Bad

Rating